live attenuated zoster vaccine

Phase 3Vaccine

CChangchun BCHT Biotechnology Co.

live attenuated zoster vaccine is one of 68 biologic programs targeting Herpse Zoster. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Herpse ZosterNot yet recruiting

Clinical TrialUnknown status

InfluenzaRecruiting

Impact of VaccinationNot yet recruiting

Herpse ZosterPhase 1

Not yet recruiting

Clinical TrialPreclinical

Unknown status

InfluenzaPhase 3

Recruiting

Impact of VaccinationPhase 3

Not yet recruiting

Competition

Competitive Landscape

136 competitors in Clinical Trial

#DrugCompanyPhaseTrials

Gemzar

Johnson & Johnson

Phase 3

3 2

Venclexta

AbbVie

Phase 3

2 3

Avelox

Bayer

Phase 3

2 4

Paraplatin

AAvyxa

Phase 3

2 5

Opzelura

DDizal Pharmaceuticals

Phase 3

1 6

Potassium Iodide

MMeda Pharmaceuticals

Phase 3

1 7

Ablysinol

CSL Behring

Phase 3

1 8

Nascobal

GGrupo Espanol de Tumores Neuroendocrinos

Phase 3

1 9

Tarceva

OOSI Pharmaceuticals

Phase 2

2 10

live attenuated zoster vaccine

CChangchun BCHT Biotechnology Co.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2029

ApprovedNot yet recruiting

Impact of Vaccination

NCT07093281

Q4 2030

Post-ApprovalRecruiting

Influenza

NCT07240922

Clinical

Trials by Indication[1]

Influenza12 trials

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Completed·UUniversity of Rochester·Phase 4·NCT01246999·34 enrolled

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Unknown status·CChangchun BCHT Biotechnology Co.·Phase 1·NCT05056519·160 enrolled

Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine

Completed·PPatricia L. Hibberd·Phase 1·NCT01545349·30 enrolled

Show 9 more trials

The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study

Recruiting·TThe University of Hong Kong·Phase 4·NCT07240922·600 enrolled

Efficacy & Safety of Nasal Influenza Immunisation in Children

Completed·IImperial College London·Phase 4·NCT02549365·276 enrolled

Nasal and Systemic Immune Responses to Nasal Influenza Vaccine

Completed·IImperial College Healthcare NHS Trust·N/A·NCT04110366·48 enrolled

Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years

Completed·SSt. Louis University·Phase 4·NCT03101462·38 enrolled

Live Versus Inactivated Influenza Vaccine Study in Hutterite Children

Completed·MMcMaster University·Phase 4·NCT01653015·4,611 enrolled

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Unknown status·CChangchun BCHT Biotechnology Co.·Phase 2·NCT05284851·2,520 enrolled

Study of Live, Attenuated Influenza Vaccination in Preterm and Full-Term Infants

Terminated·UUniversity of Rochester·Phase 4·NCT01194297·3 enrolled

Revealing Protective Immunity to Influenza Using Systems Immunology

Completed·EEmory University·Phase 4·NCT06501963·51 enrolled

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children

Completed·IImperial College London·Phase 4·NCT03735147·12 enrolled

Clinical Trial1 trial

To Explore a Bridging Index for the Effectiveness of the Clinical Trial

Unknown status·CChangchun BCHT Biotechnology Co.·N/A·NCT04825340·450 enrolled

Asthma1 trial

Safety of LAIV4 in Children With Asthma

Completed·VVanderbilt University Medical Center·Phase 4·NCT03600428·152 enrolled

Flu Vaccine1 trial

The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets

Completed·SStanford University·Phase 1·NCT03898986·18 enrolled

Immune Response1 trial

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Terminated·NNational Center for Occupational Health and Infection Control·N/A·NCT01673425·5 enrolled

3 more indications

Efficacy1 trial

Study on Efficacy of Attenuated Zoster Vaccine, Live

Completed·CChangchun BCHT Biotechnology Co.·Phase 3·NCT04334577·25,000 enrolled

Impact of Vaccination1 trial

The Impact of Live Attenuated Intranasal Influenza Vaccine Exposure on Mucosal Immunity

Not yet recruiting·UUniversity of Maryland, Baltimore·Approved·NCT07093281·25 enrolled

Herpse Zoster1 trial

A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine

Not yet recruiting·CChangchun BCHT Biotechnology Co.·Phase 1·NCT07753265·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 19 trial records for live attenuated zoster vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — live attenuated zoster vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for live attenuated zoster vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Changchun BCHT Biotechnology Co. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Phase 3[1]
Company: CChangchun BCHT Biotechnology Co.

live attenuated zoster vaccine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2029

Q4 2030

Trials by Indication[1]

Influenza12 trials

Clinical Trial1 trial

Asthma1 trial

Flu Vaccine1 trial

Immune Response1 trial

Efficacy1 trial

Impact of Vaccination1 trial

Herpse Zoster1 trial

References

Drug Info

Quick Facts

Related News